LobbyingMondelez Global lobbying by quarter
Mondelez Global's latest lobbying report covers Q2 2026, at $270K. The four quarters Q4 2025–Q3 2026 total $1.1M. Its first report covers Q4 2022; the issues it reports most are Food Industry (Safety, Labeling, etc.) and Taxation/Internal Revenue Code.
Mondelez Global
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $1.1M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $300K | 2 |
| Q1 2023 | $350K | 2 |
| Q2 2023 | $180K | 2 |
| Q3 2023 | $190K | 2 |
| Q4 2023 | $280K | 2 |
| Q1 2024 | $410K | 2 |
| Q2 2024 | $100K | 2 |
| Q3 2024 | $80K | 1 |
| Q4 2024 | $140K | 2 |
| Q1 2025 | $250K | 2 |
| Q2 2025 | $180K | 2 |
| Q3 2025 | $150K | 2 |
| Q4 2025 | $370K | 2 |
| Q1 2026 | $440K | 2 |
| Q2 2026 | $270K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Food industry$1.4M · 6 reports
- Taxation$152.5K · 2 reports
- Agriculture$62.5K · 1 reports
- Tariffs$62.5K · 1 reports
- Trade$60K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES7 reports
- SENATE7 reports
- Agriculture, Dept of (USDA)3 reports
- White House Office3 reports
- Food & Drug Administration (FDA)2 reports
- Office of Management & Budget (OMB)2 reports
- Executive Office of the President (EOP)1 reports
- Health & Human Services, Dept of (HHS)1 reports
- U.S. Trade Representative (USTR)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseMondelez Global | $3.6M | 15 quarters |
| Akin Gump Strauss Hauer & Feld | $60K | 14 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $270K |
| 07/20for Q2 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 04/20for Q4 2025 | In-house | $370K |
| 04/20for Q1 | In-house | $440K |
| 04/20for Q1 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 01/20for Q2 2025 | In-house | $180K |
| 01/20for Q4 2024 | In-house | $140K |
| 01/20for Q4 2025 | In-house | $330K |
| 01/20for Q4 2025 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 25/10/20for Q3 2025 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 25/10/20for Q3 2025 | In-house | $150K |
| 25/07/21for Q2 2025 | In-house | $160K |
| 25/07/21for Q2 2025 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 25/04/21for Q1 2025 | In-house | $250K |
| 25/04/21for Q1 2025 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 25/01/21for Q4 2024 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 25/01/21for Q4 2024 | In-house | $110K |
| 24/12/31for Q4 2024 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 24/10/21for Q3 2024 | In-house | $80K |
| 24/07/29for Q2 2024 | In-house | $100K |